Diabetology & Metabolic Syndrome · Aug 24, 2026

Association of insulin resistance-based indices with mortality among United States adults across cardiovascular-kidney-metabolic stages

By Zhang L, Wen Y, Shen Y et al.

BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome is a significant public health challenge due to its increasing prevalence and associated mortality. Insulin resistance is central to CKM syndrome, but its predictive role in all-cause, cause-specific mortality and cardiovascular outcomes remains underexplored. This study aimed to evaluate the predictive ability of waist-to-height glucose index (WyG), triglyceride-glucose ratio (TyG), and their variants as biomarkers for mortality risk in participants classified by the American Heart Association (AHA) CKM staging framework. METHODS: Using NHANES data (1999-2018), 18,050 participants aged 20-79 years were included and classified into CKM stages 0-4 according to the 2023 AHA CKM staging framework. Metabolic indices, including WyG, TyG, TyG waist circumference index (TyG-WC), TyG waist-to-height ratio (TyG-WHtR), and TyG-body mass index (TyG-BMI), were assessed for their associations with all-cause and cause-specific mortality (cardiovascular disease, diabetes, hypertension, and cancer). Logistic and Cox analyses, along with restricted cubic spline (RCS) models, were used to evaluate risk associations. Predictive performance was compared using receiver operating characteristic (ROC) curves. The subgroup analysis was carried out to test the robustness of WyG. RESULTS: Baseline analyses revealed a significant increase in CKM severity, cardiovascular prevalence, and mortality risks across quartiles of WyG, TyG, and their variants (all P < 0.001). WyG showed an AUC of 0.618 for all-cause mortality and the highest predictive performance for diabetes mortality (AUC = 0.785). The association between WyG and mortality exhibited a U-shaped curve, with both high and low levels linked to increased mortality risk. Conversely, TyG demonstrated an exponential relationship with mortality, indicating unidirectional metabolic dysregulation. Subgroup analyses revealed significant interactions between WyG and age, education, and 10-year cardiovascular disease risk scores, highlighting its robustness as an independent predictor across diverse clinical profiles. CONCLUSION: WyG demonstrated comparable discrimination for all-cause mortality and generally higher discrimination for cardiovascular and diabetes mortality compared with the other indices. These findings support WyG as a simple, integrative metabolic marker that can be readily incorporated into existing risk models to provide incremental prognostic information for mortality risk stratification.

doi.org/10.1186/s13098-026-02277-yOpen accessPubMed 43053197Biomarkers

AgingResearch.News